Search Results - "Ueyama, Azumi"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer by Haruna, Miya, Ueyama, Azumi, Yamamoto, Yoko, Hirata, Michinari, Goto, Kumiko, Yoshida, Hiroshi, Higuchi, Naoko, Yoshida, Tetsuya, Kidani, Yujiro, Nakamura, Yamami, Nagira, Morio, Kawashima, Atsunari, Iwahori, Kota, Shintani, Yasushi, Ohkura, Naganari, Wada, Hisashi

    Published in Scientific reports (30-03-2022)
    “…Regulatory T cells (Tregs) suppress the host immune response and maintain immune homeostasis. Tregs also promote cancer progression and are involved in…”
    Get full text
    Journal Article
  2. 2

    Anti-CTLA-4 treatment suppresses hepatocellular carcinoma growth through Th1-mediated cell cycle arrest and apoptosis by Morihara, Hitomi, Yamada, Tomomi, Tona, Yumi, Akasaka, Marina, Okuyama, Hirohisa, Chatani, Natsumi, Shinonome, Satomi, Ueyama, Azumi, Kuwabara, Kenji, Fujio, Yasushi

    Published in PloS one (06-08-2024)
    “…Inhibiting the cytotoxic T-lymphocyte-associated protein-4 (CTLA-4)-mediated immune checkpoint system using an anti-CTLA-4 antibody (Ab) can suppress the…”
    Get full text
    Journal Article
  3. 3

    Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis by Oku, Hisashi, Shimizu, Toshikatsu, Kawabata, Tomoji, Nagira, Morio, Hikita, Ichiro, Ueyama, Azumi, Matsushima, Shuuichi, Torii, Mikinori, Arimura, Akinori

    Published in European journal of pharmacology (20-08-2008)
    “…Pirfenidone, a broad-spectrum antifibrotic agent, is known to have efficacy in certain fibrotic disease models, and is under clinical trials in patients with…”
    Get full text
    Journal Article
  4. 4

    Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: A role for interferon-alpha in dendritic cell activation by imiquimod by Ueyama, Azumi, Yamamoto, Mina, Tsujii, Kenichiro, Furue, Yoko, Imura, Chihiro, Shichijo, Michitaka, Yasui, Kiyoshi

    Published in Journal of dermatology (01-02-2014)
    “…Topical application of imiquimod (IMQ), a Toll‐like receptor (TLR)7 ligand, can induce and exacerbate psoriasis, a chronic inflammatory skin disorder. In a…”
    Get full text
    Journal Article
  5. 5

    In situ analysis of CCR8 + regulatory T cells in lung cancer: suppression of GzmB + CD8 + T cells and prognostic marker implications by Hayashi, Yoshinori, Ueyama, Azumi, Funaki, Soichiro, Jinushi, Koichi, Higuchi, Naoko, Morihara, Hitomi, Hirata, Michinari, Nagira, Yoji, Saito, Takuro, Kawashima, Atsunari, Iwahori, Kota, Shintani, Yasushi, Wada, Hisashi

    Published in BMC cancer (23-05-2024)
    “…CCR8-expressing regulatory T cells (Tregs) are selectively localized within tumors and have gained attention as potent suppressors of anti-tumor immunity. This…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway by Tone, Mari, Iwahori, Kota, Hirata, Michinari, Ueyama, Azumi, Tani, Akiyoshi, Haruta, Jun-Ichi, Takeda, Yoshito, Shintani, Yasushi, Kumanogoh, Atsushi, Wada, Hisashi

    Published in Journal for immunotherapy of cancer (15-04-2024)
    “…BackgroundCancer immunotherapy including immune checkpoint inhibitors is only effective for a limited population of patients with cancer. Therefore, the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile by Ueyama, Azumi, Nogami, Wataru, Nashiki, Kunitaka, Haruna, Miya, Miwa, Hiroto, Hagiwara, Masaki, Nagira, Morio, Wada, Hisashi, Nagira, Yoji

    Published in The Journal of immunology (1950) (15-08-2023)
    “…Regulatory T cells (Tregs) contribute to the formation of a tumor-immunosuppressive microenvironment. CCR8 is reportedly selectively expressed in tumor Tregs,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Discovery of a potent orally bioavailable retinoic acid receptor-related orphan receptor-gamma-t (RORγt) inhibitor, S18-000003 by Sasaki, Yoshikazu, Odan, Masahide, Yamamoto, Shiho, Kida, Shiro, Ueyama, Azumi, Shimizu, Masaya, Haruna, Takayo, Watanabe, Ayahisa, Okuno, Takayuki

    Published in Bioorganic & medicinal chemistry letters (01-12-2018)
    “…[Display omitted] •Highly potent RORγt inhibitors discovered by a precise SAR study.•Detailed binding mode discussion of the compound guided by X-ray cocrystal…”
    Get full text
    Journal Article
  14. 14

    Tumor-infiltrating ICOS + Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' Tumor by Kajikawa, Hitomi, Hirata, Michinari, Haruna, Miya, Ueyama, Azumi, Hirose, Katsutoshi, Kawashima, Atsunari, Iwahori, Kota, Matsunaga, Kazuhide, Toyosawa, Satoru, Uzawa, Narikazu, Wada, Hisashi

    Published in Anticancer research (01-05-2022)
    “…Tumor immunity in the tumor microenvironment is activated in patients with feasible clinical responses to immune checkpoint inhibitors. The immunological…”
    Get full text
    Journal Article
  15. 15
  16. 16